Describing the Value of ctDNA in Clinical Practice

Opinion
Video

The key opinion leaders share their approaches for communicating about circulating tumor DNA and minimal residual disease to patients, emphasizing the significance of ctDNA testing in detecting MRD.

CN24_CRC_ATP_Seg04_Value
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      1. Mackenzie Phillips: How do you describe ctDNA and MRD to patients?
      2. Jing Yi: Why do you think it’s important to do ctDNA testing for MRD?
      Related Content